Exemestane
Who holds supplier records for Exemestane? 11 organisations hold a current record for Exemestane: an active US FDA Type II Drug Master File or a CEP. A further 8 organisations have only historical (inactive) DMF filings. 8 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (4), Italy (2), Spain (1), Taiwan (1) and 3 other countries (3).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Exemestane: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/exemestane
Reading the evidence
- 11 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 9 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (11)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Exemestane. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Cipla LimitedIndiaCEP Company GMP cert on recordActive DMF 22099 · latest filing Nov 2008
- CORAL DRUGS PVT LTDIndiaCEP Company GMP cert on recordActive DMF 38247 · latest filing Mar 2023
- CURIA SPAIN SAUSpainCEP Company GMP cert on recordActive DMF 17813 · latest filing Nov 2004
- Farmabios S.p.A.ItalyCEP Company GMP cert on recordActive DMF 26291 · latest filing Jul 2012
- SCINOPHARM TAIWAN LTDTaiwanCEPActive DMF 21175 · latest filing Dec 2007
- Shandong Anhong Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on recordActive DMF 26061 · latest filing May 2012
- SYMBIOTICA SPECIALITY INGREDIENTS SDN BHDMalaysiaCEPActive DMF 25275 · latest filing Jul 2011
- STERLING SPAItaly Company GMP cert on recordActive DMF 22439 · latest filing Jan 2009
- Sun Pharmaceutical Industries LimitedIndia Company GMP cert on recordActive DMF 28960 · latest filing Mar 2015
- Zydus Lifesciences LimitedIndia Company GMP cert on recordActive DMF 39282 · latest filing Dec 2023
- NetherlandsCEP Company GMP cert on record
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (8)
Certificates of Suitability on the EDQM register for Exemestane, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 12 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| SCINOPHARM TAIWAN LTD. Tainan | TW | CEP 2016-002 - Rev 02 Exemestane | Nov 2026 | — |
| SYNTHON B.V. Nijmegen | NL | CEP 2022-424 - Rev 02 Exemestane, Micronised | Oct 2025 | Inspected May 2024 Netherlands |
| FARMABIOS S.p.A Gropello Cairoli | IT | CEP 2018-274 - Rev 01 Exemestane, micronized | Aug 2025 | Inspected Jul 2026 Italy |
| CORAL DRUGS PRIVATE LIMITED New Delhi | IN | CEP 2023-032 - Rev 00 Exemestane | Jul 2025 | — |
| SHANDONG ANHONG PHARMACEUTICAL CO., LTD. Dezhou City | CN | CEP 2016-156 - Rev 02 Exemestane, Micronised (Form A), non-micronised | Sept 2024 | Inspected Nov 2025 Greece |
| CURIA SPAIN S.A.U. Boecillo | ES | CEP 2017-159 - Rev 06 Exemestane | Apr 2024 | Inspected Feb 2026 Spain |
| SYMBIOTICA SPECIALITY INGREDIENTS SDN. BHD. Butterworth | MY | R1-CEP 2016-116 - Rev 00 Exemestane | Aug 2023 | — |
| CIPLA LIMITED Mumbai | IN | R1-CEP 2016-072 - Rev 00 Exemestane | Aug 2022 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (8)
Organisations whose Type II DMFs for Exemestane are no longer active. These show a past filing, not current supply.
Show all 8 historical records
- Apotex Pharmachem India Pvt. Ltd.India · Inactive DMF 27167 · filed May 2013
- MAC CHEM PRODUCTS INDIA PVT LTDInactive DMF 26911 · filed Feb 2013
- China · Inactive DMF 23508 · filed Jan 2010
- India · Inactive DMF 22645 · filed Mar 2009
- ZYFINE DIV CADILA HEALTHCARE LTDInactive DMF 22578 · filed Feb 2009
- Italy · Inactive DMF 22365 · filed Dec 2008
- YANCHENG XINYI PHARM AND CHEM CO LTDInactive DMF 21441 · filed Dec 2007
- PERRIGO API LTDInactive DMF 20219 · filed Jan 2007
Overview
Exemestane is an oral steroidal aromatase inhibitor used in the treatment of estrogen-receptor positive breast cancer in postmenopausal women. It works by decreasing the amount of estrogen produced by the body, thus slowing or stopping the growth of breast cancer cells that rely on estrogen to proliferate.
Chemical identity
- IUPAC name
- 10,13-dimethyl-6-methylidene-7,8,9,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,17-dione
- Canonical SMILES
- CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
- InChIKey
- BFYIZQONLCFLEV-UHFFFAOYSA-N
- Synonyms
- Aromasin API, STL445691, VS-13397
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Aromatase Inhibitor
- Mechanism of action
- Aromatase Inhibitors
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Exemestane?
11 organisations hold an active US FDA Type II Drug Master File or a CEP for Exemestane: Cipla Limited (India), CORAL DRUGS PVT LTD (India), CURIA SPAIN SAU (Spain), Farmabios S.p.A. (Italy), SCINOPHARM TAIWAN LTD (Taiwan), Shandong Anhong Pharmaceutical Co., Ltd. (China), SYMBIOTICA SPECIALITY INGREDIENTS SDN BHD (Malaysia) and STERLING SPA (Italy), and 3 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Exemestane Drug Master Files are active?
Cipla Limited (DMF 22099), CORAL DRUGS PVT LTD (DMF 38247), CURIA SPAIN SAU (DMF 17813), Farmabios S.p.A. (DMF 26291), SCINOPHARM TAIWAN LTD (DMF 21175), Shandong Anhong Pharmaceutical Co., Ltd. (DMF 26061), SYMBIOTICA SPECIALITY INGREDIENTS SDN BHD (DMF 25275) and STERLING SPA (DMF 22439) and 2 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Exemestane records mean?
8 organisations have only inactive Type II DMFs for Exemestane. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Exemestane have a European Certificate of Suitability?
Yes. 8 organisations hold a valid CEP for Exemestane on the EDQM register, including SCINOPHARM TAIWAN LTD. Tainan (TW), SYNTHON B.V. Nijmegen (NL), FARMABIOS S.p.A Gropello Cairoli (IT), CORAL DRUGS PRIVATE LIMITED New Delhi (IN), SHANDONG ANHONG PHARMACEUTICAL CO., LTD. Dezhou City (CN) and CURIA SPAIN S.A.U. Boecillo (ES) and 2 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Exemestane supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Exemestane?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.